VarCov Co’s Bicara Therapeutics BCAX Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAX
SL
VarCov Co's BCAX Position: Q3 2026 in Review
VarCov Co increased its Bicara Therapeutics (BCAX) stake by 10% in Q3 2026, buying an estimated $26.5K and bringing the position to 11,159 shares worth $208K. The position accounts for 0.1% of the portfolio, ranked #307.
VarCov Co first reported a position in BCAX in Q4 2025 and has held it in 4 quarters since. The position peaked at $300K in Q2 2026. 169 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.
- VarCov Co held 11,159 shares of Bicara Therapeutics worth $208K as of Q3 2026.
- VarCov Co bought 1,060 Bicara Therapeutics shares in Q3 2026, an estimated $26.5K.
- Bicara Therapeutics made up 0.1% of VarCov Co's portfolio in Q3 2026, its #307 holding.
- VarCov Co first reported a position in Bicara Therapeutics in Q4 2025 and has held it in 4 quarters since.
- VarCov Co's Bicara Therapeutics position peaked at $300K in Q2 2026.
- 169 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.
Based on VarCov Co's 13F filing for Q3 2026, filed 16 Nov 2026.